Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity March 31, 2026 Read More »
Weight regain after cessation of medication for weight management: Systematic review and meta-analysis November 6, 2025 Read More »
MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies September 5, 2025 Read More »
Repeated Withdrawal of a GLPR Agonist Induces Hyperleptinemia and Deteriorates Metabolic Health in Obese Aging UM-HET3 Mice August 23, 2025 Read More »